Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inhibition of HIV-1 protease by a boron-modified polypeptide.

A D Pivazyan1, D S Matteson, L Fabry-Asztalos

  • 1Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06510, USA. pivazya@attglobal.net

Biochemical Pharmacology
|September 7, 2000
PubMed
Summary

New boronated tetrapeptides show significant inhibitory activity against human immunodeficiency virus 1 (HIV-1) protease, including drug-resistant variants. These compounds offer potential for developing novel protease inhibitors and studying enzyme biochemistry.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Copper-catalyzed three-component thiocyanosulfonylation of allenes.

Chemical communications (Cambridge, England)·2026
Same author

[Experimental study on interleukin-10 secretion from M2 macrophages promoting osteogenic differentiation of rat bone marrow mesenchymal stem cells post-radiation].

Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology·2026
Same author

Phase singularities near reverse energy flows in tightly focused optical vortices.

Applied optics·2026
Same author

[The relationship between preoperative thyroglobulin and recurrence risk as well as treatment response in differentiated thyroid cancer].

Zhonghua yi xue za zhi·2026
Same author

[The multi-center mid-term clinical outcomes of combined complete preservation of chordal structure mitral valve replacement with total anatomic complete arterial myocardial revascularization for coronary patients with moderate-to-severe or severe ischemic mitral regurgitation].

Zhonghua wai ke za zhi [Chinese journal of surgery]·2024
Same author

[Etiological characteristics and whole genome sequence analysis of Clostridium perfringens causing a food poisoning outbreak].

Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]·2024

Area of Science:

  • Biochemistry
  • Medicinal Chemistry
  • Virology

Background:

  • Human immunodeficiency virus 1 (HIV-1) protease is a critical target for antiviral therapy.
  • Developing novel inhibitors effective against resistant strains remains a significant challenge.

Purpose of the Study:

  • To synthesize and evaluate boronated tetrapeptides as potential inhibitors of HIV-1 protease.
  • To investigate the mechanism of inhibition and activity against drug-resistant HIV-1 protease variants.

Main Methods:

  • Synthesis of six boronated tetrapeptides, replacing the carboxy moiety of phenylalanine with dihydroxyboron.
  • Enzymatic assays to determine inhibitory activity (K(i) values) against HIV-1 protease.
  • Fluorescence analysis to study enzyme-inhibitor complex formation.

Related Experiment Videos

Main Results:

  • Synthesized boronated tetrapeptides competitively inhibited HIV-1 protease with K(i) values from 5 to 18 microM.
  • Ac-Thr-Leu-Asn-PheB demonstrated potent inhibition (K(i) = 5 microM), while its non-boronated analog was inactive.
  • Inhibition was observed against an HIV-1 protease variant resistant to existing inhibitors.
  • Fluorescence quenching indicated the formation of a boronated peptide/HIV-1 protease complex.

Conclusions:

  • Boronation is crucial for the observed enzyme inhibitory activity.
  • Boronated tetrapeptides are effective against drug-resistant HIV-1 protease.
  • These compounds show promise as research tools and potential leads for developing new protease dimerization inhibitors.